Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
OptimizeRx Corp
Royce & Associates LP has filed an amended Schedule 13G regarding its beneficial ownership in OptimizeRx Corp. This filing provides an update on the investment firm's current stake and ownership status in the company.…more
OptimizeRx Corp
Andrew J. D'Silva, an executive at OptimizeRx Corp, has filed a Form 4 to report changes in his beneficial ownership of company securities. This filing serves as a standard disclosure regarding insider equity transactions.…more
OptimizeRx Corp
Andrew J. D'Silva, an executive at OptimizeRx Corp, filed a Form 4 report on September 2, 2026, regarding changes in beneficial ownership of securities as of September 1, 2026. This filing serves as an official notification to the SEC regarding the insider's change in stock holdings.…more
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
OptimizeRx Partners with The Trade Desk via OpenPath
OptimizeRx is integrating with The Trade Desk's OpenPath to provide advertisers direct access to its network of 800,000 verified healthcare professionals. This partnership allows life sciences marketers to incorporate point-of-care inventory into their broader programmatic media strategies.…more
●●●●●●●● ●●●●● ●●●●●●
OptimizeRx has expanded its AI-driven NLAB tool to unify healthcare professional and consumer audience targeting within a single workflow. This update represents a technical enhancement to improve marketing efficiency, though it does not provide immediate evidence of revenue impact.…more
●●●●●●●● ●●●●● ●●●●●●
OptimizeRx announced that its management will participate in the 10th Annual Lake Street Best Ideas Growth Conference. This is a standard investor relations event and does not provide new material financial information.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.